title: Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.
authors.forename: Michael
authors.initials: M
authors.lastname: Rader
authors.forename: Carsten
authors.initials: C
authors.lastname: Goessl
authors.forename: Ze
authors.initials: Z
authors.lastname: Cong
mesh_terms: D000911:Antibodies, Monoclonal / Q000191:economics*; D050071:Bone Density Conservation Agents / Q000191:economics*; D001859:Bone Neoplasms / Q000191:economics*; D003362:Cost-Benefit Analysis / Q000191:economics*; D004164:Diphosphonates / Q000191:economics*; D006801:Humans; D007093:Imidazoles / Q000191:economics*; D008297:Male; D011471:Prostatic Neoplasms / Q000191:economics*
chemical_list: D000911:Antibodies, Monoclonal; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles